Belgium· BE-AMP-SAM660469-00

Kinpeygo 4 mg

A budesonide product containing budesonide, registered in Belgium by Stada Arzneimittel. The same ATC class is registered in 16 of our 19 countries.

ATC A07EA06

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedKinpeygo 4 mgATCA07EA06REGISTER NO.BE-AMP-SAM660469-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Budesonide is registered in 16 of 19 countries.

Countries holding a registration under ATC A07EA06 (budesonide), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose

Budesonide · ATC A07EA06

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of budesonide costs, country by country.

Normalised to the WHO defined daily dose (9 mg), the median price runs from $2.36 in Italy to $4.97 in Switzerland — a ×2.1 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Budesonide · price per daily dose (9 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$4.97
  • IT Italy$2.36
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Budesonide
Manufacturer
Stada Arzneimittel
Country
Belgium (BE)
ATC code
A07EA06
ATC class
Budesonide
Defined daily dose
9 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    4880316
  • be_apb
    7742117

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

687 interactions on record for budesonide.

Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Budesonide · interactions on record

687 records

  • 62 severe
  • 260 moderate
  • 27 minor
  • 337 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • Bempedoic acidC10AX15severe
  • MifepristoneG03XB01severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Budesonide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All budesonide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Budenofalk, Budo-San
  • Bulgaria · Airbudenid, Буденофалк
  • Cyprus · Axelovert, Biosonide
  • Czechia · Budenofalk, Budenofalk Uno
  • Germany · Aquacort, Budapp Nasal
  • Denmark · Benarhin, Budenofalk
  • Estonia · Budesonid Sandoz, Budesonide
  • Spain · Budena, Budesonida
  • Finland · Budenofalk, Budesonid Easyhaler Orion
  • France · Budésonide Arrow, Budesonide Biogaran
  • United Kingdom (Northern Ireland) · Benacort, Benacort Hayfever Relief For Adults
  • Greece · Aurid, Axelovert
  • Croatia · Budelin Novolizer, Budosan
  • Hungary · Budenofalk, Budesonid Easyhaler
  • Ireland · Budenofalk, Budesonide Azure
  • Iceland · Budesonide Stada, Cortiment
  • Italy · Aircort, Bidien
  • Liechtenstein · Jorveza, Kinpeygo
  • Lithuania · Budenofalk, Budesonide Ferring
  • Luxembourg · Budenofalk, Budesonide Eg
  • Latvia · Budenofalk, Budesonid Sandoz
  • Malta · Budesonida Aldo-Unión, Budesonide Azure
  • Netherlands · Budenofalk, Budenofalk Schuim
  • Norway · Budenofalk, Budesonid Medical Valley
  • Poland · Bds N, Benodil
  • Portugal · Aeromax, Budenofalk
  • Romania · Budenofalk, Budenofalk Uno
  • Sweden · Budaxiro, Budenofalk
  • Slovenia · Budenofalk, Budesonid Easyhaler Orion
  • Slovakia · Budelin Novolizer, Budenofalk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2b976e2c-4ceb-4698-bcb8-de2662b3f61f
GET /v1/drugs/2b976e2c-4ceb-4698-bcb8-de2662b3f61f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Modified-release capsule, hard",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Kinpeygo 4 mg",
  "name_fr": "Kinpeygo 4 mg",
  "name_nl": "Kinpeygo 4 mg",
  "amp_code": "SAM660469-00",
  "strengths": [
    "4.0000",
    "4.0000",
    "4.0000",
    "4.0000",
    "4.0000",
    "230.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Budesonide",
    "Sucrose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Budesonide",
  "authorisation_numbers": [
    "EU/1/22/1657/001",
    "EU/1/22/1657/002",
    "EU/1/22/1657/003",
    "EU/1/22/1657/004"
  ]
}

See everything about budesonide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.